A new algorithm designed to consider all forms of diabetes when diagnosing patients is among the additions in the American ...

"Dr. Babak Moein in Los Angeles emphasizes that Type 2 diabetes treatment should follow an individualized algorithm combining lifestyle modification, glycaemic monitoring, and targeted medical therapy ...

The Government of India has tightened regulation of GLP-1 drugs used for diabetes and weight loss, restricting prescriptions ...

Redefining obesity based not only on body mass index (BMI) but on whether excess body fat is causing measurable health ...

Many researchers prefer the “live” data that comes from real-world results while still acknowledging potential shortcomings.

A new study led by Marc D. Breton, PhD, found that a University of Virginia Center for Diabetes Technology-developed algorithm – paired with a continuous glucose monitor – can help users better manage ...

The global conversation around obesity and type 2 diabetes management has shifted dramatically in recent years, largely due to the rise of GLP-1 receptor compounds. Among them, semaglutide has emerged ...

New recommendations suggest that some people should start trying to lower their cholesterol as early as age 30.

A subgroup analysis of the VASALIUS-CV trial showed evolocumab significantly cut LDL cholesterol and cardiovascular event risk in people with diabetes but no known atherosclerosis.

A University of Virginia Center for Diabetes Technology-developed algorithm—paired with a continuous glucose monitor—can help users better manage their type 2 diabetes by recommending insulin-dose ...

MiniMed Group Inc. is back as a locally based publicly traded company, having come full circle after 30 years. The Northridge ...